jak vidite vyvoj PARSu?
Pharmos' Disappointing Brain-Injury Treatment 20.12.2004
NEW YORK - Hopes for an experimental treatment that had the potential to help the 85,000 Americans who suffer long-term disability each year due to traumatic brain injury were dashed this morning when Pharmos said that its drug, dexanabinol, failed to show statistically significant improvement in a pivotal late-stage clinical trial.